Mannkind Corporation
Clinical trials sponsored by Mannkind Corporation, explained in plain language.
-
Inhaled insulin trial aims to simplify diabetes management for teens
Disease control Recruiting nowThis study tests a new way to manage type 1 diabetes in teens aged 10 to 17 who were just diagnosed. Instead of multiple daily injections, participants use inhaled insulin (Afrezza) along with a long-acting insulin shot. The goal is to see if this combination helps keep blood sug…
Phase: PHASE2 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated May 26, 2026 06:49 UTC
-
New inhaled therapy for lung scarring enters early safety trial
Symptom relief Recruiting nowThis early-stage study tests an inhaled form of nintedanib (MNKD-201) in 24 adults with idiopathic pulmonary fibrosis (IPF), a lung-scarring disease. The main goal is to check safety and how the body processes the drug, not to treat the disease. Participants receive either the dr…
Phase: PHASE1 • Sponsor: Mannkind Corporation • Aim: Symptom relief
Last updated May 26, 2026 06:48 UTC